Ottobock invests in NeuroTech company ONWARD® Medical
more
Stories about Therapie
RHEACELL announces FDA approval for Phase 3 study in refractory, non-curable CVU
more- 2
Fundació Puigvert validates a new tool capable of selecting the most suitable antibiotic for uncomplicated urinary tract infections within 45 minutes.
One documentmore - 10
Gerresheimer: New pictures available
more Gerresheimer expands capacities for Medical Systems in the USA
moreDr. Reddy's subsidiary betapharm, and Theranica launch Nerivio® in Germany to provide patients with drug-free migraine treatment
moreResearch Success in Rare Disease / RHEACELL receives positive signal for accelerated stem cell development program in rare ‚Butterfly Disease‘
moreRising Focus on 'Inceptor' as a Type 2 Diabetes Therapeutic Target
moreBiomay Announces its Successful Support of Approval of First CRISPR/Cas9-based Therapy
moreNew Source of Stem Cells in Injury-Affected Brains of Patients
more- 2
Press release : People with Parkinson’s experience variations in effects of oral medicines, but lack advice, international survey reveals
One documentmore A New Ally in Fighting Brain Diseases: Our Very Own Skull
more- 2
CARAMBA: New Hope for Multiple Myeloma Patients
more New Approach in Cancer Therapy With Innovative Mechanism-of-Action for Ferroptosis Induction
moreRHEACELL announces “First Patient In”: EB-Haus in Salzburg, Austria starts pivotal study for stem cell therapy for severe forms of Epidermolysis bullosa that is longed for by those affected
moreThe world's first Extended Isolated Stopflow Limb Infusion (EISLI) to treat osteosarcoma results in complete remission
moreStem cell therapy for “Butterfly disease” / RHEACELL receives ‘Partners in Progress Award’ from debra of America for Epidermolysis Bullosa research
moreKlinik für Prostata-Therapie Heidelberg
Focal therapy for prostate cancer: Reliable diagnosis leads to gentle treatment
morePress Information: Ottobock strengthens its NeuroMobility business area
moreNew Ultra-Sensitive Leukemia Blood Test Delivered by Sysmex Inostics
moreGastrulation research reveals novel details about embryonic development
moreInvestment breakthrough for BrainRepair UG start-up – Stem cell treatment for newborns / Dr. Metin Colpan, founder of Nasdaq listed Qiagen N.V. acquired 5% of BrainRepair UG shares worth EUR 15M
more- 3
High-tech prosthesis for enhanced safety: New Kenevo knee joint available
more - 2
Lindis Biotech develops immunotherapy against bladder cancer
One documentmore - 3
World Cancer Day: Start-ups at the IZB develop innovative cancer drugs and diagnostic tools
One documentmore Merger: Newly-formed Semdor Pharma Group becomes one of Europe's leading pharmaceutical companies for narcotics and medical cannabis
moreRegulatory breakthrough for BrainRepair UG start-up - Stem cell treatment for newborns /EMA Orphan Drug Designation is followed by agreement on Paediatric Investigation Plan
more- 2
Innovation: Intelligent bacteria demonstrate high efficacy in the treatment of widespread disease irritable bowel syndrome with typical symptoms of recurrent diarrhoea, abdominal pain, bloating and constipation
more - 2
Beta cells from stem cells: Potential for cell replacement therapy
more Hitachi Medical Systems Europe Holding AG
2Hitachi and Centre Léon Bérard cancer center in Lyon to launch a research collaboration in the fight against cancer with AI
more
12Next